Synthesis and Anti-Hepatoma Activities of U12 Derivatives Arresting G0/G1 Phase and Inducing Apoptosis by PI3K/AKT/mTOR Pathway.

Pharmaceuticals (Basel) · 2022 · PMC8781819 · PMID 35056164

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

an increasing trendno p-value reported

Besides, there was no difference in body weight of nude mice in the U12a treatment group compared with the control group, and both had an increasing trend, while the body weight of 5-Fu treatment group possessed obvious side effects with a decreasing trend ( Figure 6 E).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.